Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib

By White W.B.   Faich G.   Borer J.S.   Makuch R.W.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 14-15

Elsevier

Access to resources Recommend Favorite

Efficacy and Safety of the Selective Cyclooxygenase-2 Inhibitor Celecoxib in the Treatment of Rheumatoid Arthritis and Osteoarthritis in Japan

By  

Digestion, Vol. 83, Iss. 1-2, 2010-11 ,pp. : 108-123

Karger

Access to resources Recommend Favorite

Regulation of glutathione in cardiac myocytes

By Li S.   Li X.   Rozanski G.J.  

Journal of Molecular and Cellular Cardiology, Vol. 35, Iss. 9, 2003-09 ,pp. : 1145-1152

Elsevier

Access to resources Recommend Favorite

Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam

By Maehata Yuji  

Journal of Gastroenterology, Vol. 47, Iss. 4, 2012-04 ,pp. : 387-393

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of cardiac contractile and intracellular Ca²⁺ response between estrogen and phytoestrogen α-zearalanol in ventricular myocytes

By Duan Jinhong   Esberg Lucy   Dai Shunling   Aberle Nicholas   Lopez Faye   Ren Jun  

Endocrine Journal, Vol. 24, Iss. 1, 2004-06 ,pp. : 33-38

Humana Press, Inc

Access to resources Recommend Favorite